A Phase I Study of RC1416 Injection

Clinical trial NCT06067490 · COMPLETED

Trial details

NCT number: NCT06067490
Sponsor: Nanjing RegeneCore Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-06-29
Primary completion: 2024-05-14
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.